Page last updated: 2024-09-04

moxifloxacin and cantharidin

moxifloxacin has been researched along with cantharidin in 1 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(cantharidin)
Trials
(cantharidin)
Recent Studies (post-2010) (cantharidin)
3,1575521,69087527307

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)cantharidin (IC50)
Protein phosphatase 1BHomo sapiens (human)1.78
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)3.6
Serine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)1.78
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B Gallus gallus (chicken)0.63

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunner, M; Eichler, HG; Lackner, E; Möller, JG; Müller, M; Stass, H1

Trials

1 trial(s) available for moxifloxacin and cantharidin

ArticleYear
Penetration of moxifloxacin into peripheral compartments in humans.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:10

    Topics: 4-Quinolones; Adult; Anti-Infective Agents; Area Under Curve; Aza Compounds; Blister; Cantharidin; Fluoroquinolones; Humans; Male; Microdialysis; Moxifloxacin; Quinolines; Saliva; Skin Diseases; Time Factors

1999